Clinical Trials
Search every registered clinical trial in the US public registry — by sponsor, drug, condition, or NCT. Phase, status, enrollment, primary completion date. The pre-meeting read on a biotech deal.
Why this exists
Healthcare and biotech diligence rests on the trial data. Phase, recruiting status, and primary completion are tells about whether a pipeline is real. The full record at clinicaltrials.gov is mandatory for FDA-regulated US trials — sponsors register or face civil penalties. Pair with FDA Drug Recalls for the post-approval surveillance angle.
Frequently asked questions
What does Clinical Trials search?
Every registered clinical trial in the U.S. public registry — by sponsor, drug, condition, or NCT identifier. Returns phase (1/2/3/4), status (recruiting, active, completed, terminated), enrollment count, primary completion date, and intervention details.
Is registration mandatory?
Yes for FDA-regulated U.S. trials — sponsors must register at ClinicalTrials.gov before enrollment begins or face civil penalties. Coverage extends to many international trials voluntarily registered. The registry is the canonical record.
Biotech-diligence use case?
Pre-investment pipeline verification (does the sponsor's claimed pipeline match registered trials?), competitor-pipeline monitoring, KOL diligence (which trials a researcher leads), and FDA-approval timeline forecasting based on primary completion dates.